Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZYDUS LIFESCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
TEVA PHARMA
Dec-13
ZYDUS LIFESCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4953,459-   
Low Rs3193,005-   
Sales per share (Unadj.) Rs170.31,985.4-  
Earnings per share (Unadj.) Rs19.8124.0-  
Cash flow per share (Unadj.) Rs26.9284.5-  
Dividends per share (Unadj.) Rs6.00108.57-  
Avg Dividend yield %1.53.4 43.9%  
Book value per share (Unadj.) Rs173.02,205.4-  
Shares outstanding (eoy) m1,012.20848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.41.6 146.9%   
Avg P/E ratio x20.626.1 79.0%  
P/CF ratio (eoy) x15.111.4 133.1%  
Price / Book Value ratio x2.41.5 160.5%  
Dividend payout %30.387.5 34.7%   
Avg Mkt Cap Rs m412,1442,741,007 15.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m24,5640-   
Avg. sales/employee Rs Th037,459.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,340.1-  
INCOME DATA
Net Sales Rs m172,3741,683,624 10.2%  
Other income Rs m4,7460-   
Total revenues Rs m177,1201,683,624 10.5%   
Gross profit Rs m29,677461,061 6.4%  
Depreciation Rs m7,227136,089 5.3%   
Interest Rs m1,29933,069 3.9%   
Profit before tax Rs m25,897291,903 8.9%   
Minority Interest Rs m01,326 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-191,619 -0.0%   
Tax Rs m5,878-3,564 -164.9%   
Profit after tax Rs m20,019105,175 19.0%  
Gross profit margin %17.227.4 62.9%  
Effective tax rate %22.7-1.2 -1,859.1%   
Net profit margin %11.66.2 185.9%  
BALANCE SHEET DATA
Current assets Rs m100,0821,137,114 8.8%   
Current liabilities Rs m55,267991,659 5.6%   
Net working cap to sales %26.08.6 300.9%  
Current ratio x1.81.1 157.9%  
Inventory Days Days5091 55.4%  
Debtors Days Days9496 97.5%  
Net fixed assets Rs m144,776549,909 26.3%   
Share capital Rs m1,0124,144 24.4%   
"Free" reserves Rs m174,1460-   
Net worth Rs m175,1581,870,187 9.4%   
Long term debt Rs m0860,875 0.0%   
Total assets Rs m244,9403,847,621 6.4%  
Interest coverage x20.99.8 213.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.70.4 160.8%   
Return on assets %8.73.6 242.2%  
Return on equity %11.45.6 203.2%  
Return on capital %15.54.9 314.8%  
Exports to sales %39.20-   
Imports to sales %11.90-   
Net fx Rs m47,0330-   
CASH FLOW
From Operations Rs m26,888268,283 10.0%  
From Investments Rs m11,712-95,063 -12.3%  
From Financial Activity Rs m-44,004-321,823 13.7%  
Net Cashflow Rs m-5,338-148,604 3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare ZYDUS LIFESCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ZYDUS LIFESCIENCES With: LASA SUPERGENERICS  DECCAN HEALTH CARE  ANG LIFESCIENCES INDIA  GUJ.TERC LAB  MEDICO REMEDIES   



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.